Home › Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment
 

Keywords :   


Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment

2015-07-18 19:52:36| Biotech - Topix.net

Geron and partner Johnson & Johnson missed their self-imposed target date for the start of trial enrollment, yet Geron's stock hit its 52-week high post the deadline. I am speculating the delay may be driven by JNJ laying the groundwork for a possible Breakthrough Drug Therapy designation for Imetelstat.

Tags: study locations phase begins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »